French Industry Attacks Price Cut & Drug Shortage Plans
Leem says new stock obligations would add “a new level of complexity”
Executive Summary
The French government’s plans for more price cuts and new obligations on manufacturers to avert drug shortages will add another layer of complexity to an already complicated operating environment, says the industry.
You may also be interested in...
Belgian Court Overturns Parallel Export Ban
A ban on the parallel exporting of medicines from Belgium did not achieve the desired objective of preventing drug shortages, and was also against EU rules, the Constitutional Court has ruled.
Over-Regulation Is Damaging French Pharma Sector
Leem says “Inconsistent and unpredictable” policies are hitting industry’s competitiveness and limiting patients’ access to new medicines.
Olon Expands On Multiple Fronts
Italian API and CDMO specialist Olon is expanding its high-potency capabilities at a site in India, at the same time as unveiling plans to invest a further €30m in a domestic biotech hub.